OR7E35P

Across TCGA pan-cancer cohorts, OR7E35P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR7E35P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR7E35P RNA is repressed in tumor relative to normal tissue. In most cancer types OR7E35P is over-expressed in tumor, although a few such as BRCA and COAD show the opposite, repressed pattern.

BRCA, THCA, and COAD are the cancer types where OR7E35P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E35P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	−0.059	<.001	6	view →
THCA	All	All	+0.074	.011	2	view →
COAD	All	III,IV	−0.030	.032	2	view →
THCA	Male	III,IV	−0.048	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 3 lineages.

OR7E35P–BRCA

Open the BRCA breakdown →